©2009 The WJG Press and Baishideng.
World J Gastroenterol. Nov 14, 2009; 15(42): 5279-5286
Published online Nov 14, 2009. doi: 10.3748/wjg.15.5279
Published online Nov 14, 2009. doi: 10.3748/wjg.15.5279
Table 1 The Charlson comorbidity index (CCI)[12]
| Weight1 | Comorbid condition |
| 1 | Myocardial infarction |
| Congestive heart failure | |
| Peripheral vascular disease | |
| Cerebrovascular disease (except hemiplegia) | |
| Dementia | |
| Chronic obstructive pulmonary disease | |
| Connective tissue disease | |
| Peptic ulcer disease | |
| Mild liver disease | |
| Diabetes (without complications) | |
| 2 | Hemiplegia |
| Moderate or severe renal disease | |
| Diabetes with end-organ damage (retinopathy, neuropathy, etc) | |
| Any second solid tumor (nonmetastatic), leukemia or lymphoma | |
| 3 | Moderate or severe liver disease |
| 6 | Metastatic solid tumor |
| AIDS |
- Citation: Fernández-Ruiz M, Guerra-Vales JM, Colina-Ruizdelgado F. Comorbidity negatively influences prognosis in patients with extrahepatic cholangiocarcinoma. World J Gastroenterol 2009; 15(42): 5279-5286
- URL: https://www.wjgnet.com/1007-9327/full/v15/i42/5279.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.5279